Mergers & Acquisitions

  • October 27, 2025

    Holland & Knight's CFIUS Team Leader Jumps To Weil

    The leader of Holland & Knight LLP's Committee on Foreign Investment in the United States and industrial security team has made the move to Weil Gotshal & Manges LLP in Washington, D.C., the firm announced Monday.

  • October 27, 2025

    Trian, General Catalyst Make $7.2B Play For Janus Henderson

    Janus Henderson Group said Monday it has received a $7.2 billion buyout offer from Trian Fund Management LP and General Catalyst Group Management LLC, which say the British asset management firm could more effectively achieve its goals as a private company.

  • October 27, 2025

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court and Delaware Supreme Court saw another busy week of disputes spanning biotech milestones, reincorporation showdowns, shareholder voting schemes and cryptocurrency fiduciary rights.

  • October 27, 2025

    Compass Pushes For Redfin Docs In Zillow Antitrust Fight

    Compass Inc. has urged a New York federal court presiding over the brokerage's antitrust suit against property listings company Zillow Inc. to order another property listings company, Redfin Corp., to provide copies of drafts of blog posts written by Redfin's CEO as well as a copy of an allegedly anticompetitive Zillow-Redfin rental agreement.

  • October 27, 2025

    Top FTC Atty In Meta And Amazon Cases Joins WilmerHale

    A former chief trial counsel at the Federal Trade Commission's Bureau of Competition, who was one of the lead attorneys on the agency's landmark monopolization cases against Amazon and Meta, has joined WilmerHale's Washington, D.C. office, the firm announced Monday.

  • October 27, 2025

    Paul Weiss, K&L Gates Lead $660M Albemarle, Ketjen Deals

    K&L Gates LLP-advised Albemarle Corp. on Monday announced that it has agreed to sell a majority stake in Ketjen Corp.'s refining catalyst solutions business to Paul Weiss Rifkind Wharton & Garrison LLP-led private equity shop KPS Capital Partners, and separately announced to sell all of its 50% interest in a joint venture it has with Ketjen to Axens SA in two deals that will provide the company with pre-tax proceeds of around $660 million.

  • October 27, 2025

    Schroders Portfolio Biz Agrees Sale To Data Co. For $1.7B

    Schroders Capital Global Innovation Trust PLC said Monday that its portfolio company, Securiti AI, has signed an agreement to be acquired by private equity-backed business Veeam Software for approximately $1.7 billion.

  • October 27, 2025

    Wachtell-Led Huntington Strikes $7.4B Deal For Cadence Bank

    Huntington Bancshares Inc. said Monday it has agreed to acquire Cadence Bank for $7.4 billion in one of the top banking sector deals of 2025, with Wachtell Lipton advising Huntington and Sullivan & Cromwell guiding Cadence. 

  • October 27, 2025

    UK Raises Antitrust Concern Over £1.2B Greencore Deal

    The Competition and Markets Authority said on Monday that Greencore's planned £1.2 billion ($1.6 billion) deal for meals producer Bakkavor might harm competition in the U.K.'s market for chilled sauces.

  • October 27, 2025

    Covington Helps Novartis Buy Avidity Biosciences For $12B

    Swiss pharmaceutical giant Novartis AG has said it will buy Avidity Biosciences, a U.S. developer of therapeutics for muscle diseases, for approximately $12 billion in a move to boost its neuroscience portfolio.

  • October 26, 2025

    7 Firms Steer $2.1B Take-Private Deal For Plymouth REIT

    Real estate investment firm Makarora Management LP and Ares Management Corp. have agreed to acquire and take private Plymouth Industrial REIT Inc. in a $2.1 billion cash deal guided by seven law firms, coming three months after a competing buyout offer for Plymouth.

  • October 24, 2025

    JPMorgan Accuses Charlie Javice Of 'Abusive' Atty Fee Billing

    JPMorgan Chase & Co. on Friday asked a Delaware state judge to reverse a 2023 order requiring the bank to cover the legal fees of convicted Frank founder Charlie Javice, arguing that the court must put a stop to her "abusive billing."

  • October 24, 2025

    X Corp. Says Ex-Twitter Workers' Bid Is Too Little, Too Late

    Elon Musk's X Corp. told a Delaware federal judge that six former Twitter workers' bid to revive their dismissed severance claims by raising fresh contract theories and stale arbitration testimony is "far too little, far too late."

  • October 24, 2025

    Avalara Investors Fight Stay In $8.4B Buyout Dispute

    Shareholders of tax software company Avalara are fighting a motion by the company in Washington federal court to stay litigation accusing it of misleading investors ahead of an $8.4 billion deal to take the company private.

  • October 24, 2025

    Off The Bench: NBA Gambling Woes, Golfer's $50M Trial Win

    In this week's Off The Bench, the NBA faces a gambling scandal during its opening week, a Florida jury hands golfer Jack Nicklaus a $50 million victory in his defamation lawsuit, and DraftKings and the NHL step into the realm of prediction markets.

  • October 24, 2025

    Sterlington Founder Talks C-Suite Guidance After $40B Deal

    On the heels of representing Aligned Data Centers' management in the company's $40 billion sale, Sterlington PLLC founder Chris Harrison spoke with Law360 about fundamental changes reshaping negotiations with buyers as private equity strategies evolve.

  • October 24, 2025

    Paris-Based SPAC Targets US Acquisition After Raising $100M

    French special purpose acquisition company LaFayette Acquisition Corp. began trading publicly on Friday after raising $100 million in its U.S. initial public offering, with plans to target U.S. companies in a range of industries.

  • October 24, 2025

    RunItOneTime Tells Judge Debtor In Talks For More DIP Cash

    RunItOneTime LLC told a Texas bankruptcy judge on Friday it is in talks with its post-petition financing lender for more funds as it prepares to face the loss of operating cash from assets subject to sales the debtor hopes to close.

  • October 24, 2025

    Eli Lilly Buying Eye Disease Biotech For Up To $262M

    Ropes & Gray LLP-advised Eli Lilly said Friday it has agreed to acquire Cooley LLP-guided Adverum Biotechnologies, a clinical-stage company developing gene therapies for eye diseases, for up to roughly $262 million. 

  • October 24, 2025

    Taxation With Representation: Latham, Wachtell, Gibson Dunn

    In this week's Taxation With Representation, Meta announces a joint venture with Blue Owl Capital to fund the development of a data center campus in Louisiana, private equity giants acquire medical technology company Hologic Inc., and National Fuel Gas Co. buys CenterPoint Energy Inc.'s Ohio natural gas utility business.

  • October 24, 2025

    CMA Concerned Over Aramark Deal For Scottish Catering Co.

    Britain's antitrust enforcer has clarified its concerns with Aramark Group's completed acquisition of Scottish catering company Entier Ltd. over the supply of catering and related services for the offshore energy sector.

  • October 24, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen the Financial Conduct Authority launch legal action against a Chinese cryptocurrency exchange, The Londoner magazine face a defamation claim from an entrepreneur accused of "scamming" Knightsbridge landlords, and Gucci sued by its cosmetics supplier as L'Oréal announces plans to buy the Italian fashion house's beauty brand. Here, Law360 looks at these and other new claims in the U.K.

  • October 24, 2025

    Warburg Pincus, Permira Get More Time To Bid For JTC

    Professional services provider JTC said Friday that the takeover panel has given two separate private equity firms an extension to table formal offers to acquire the professional services or walk away.

  • October 23, 2025

    Chancery Maps Out Math For Hefty Drug Co. Breach Interest

    A Delaware vice chancellor late Thursday issued a road map for calculating tens of millions of dollars in interest due after a ruling in June that Alexion Pharmaceuticals failed a "best efforts" duty to fulfill an autoimmune drug candidate deal with Syntimmune Inc.

  • October 23, 2025

    Japan's Jera Paying $1.5B For Louisiana Shale Gas Assets

    Japanese power company Jera Co. said Thursday it has agreed to acquire shale gas assets in Louisiana from Williams Cos. and GEP Haynesville II LLC for about $1.5 billion, with Baker Botts LLP steering Jera on the deal. 

Expert Analysis

  • Opinion

    It's Time For The Judiciary To Fix Its Cybersecurity Problem

    Author Photo

    After recent reports that hackers have once again infiltrated federal courts’ electronic case management systems, the judiciary should strengthen its cybersecurity practices in line with executive branch standards, outlining clear roles and responsibilities for execution, says Ilona Cohen at HackerOne.

  • Considering Judicial Treatment Of The 2023 Merger Guidelines

    Author Photo

    Courts have so far primarily cited the 2023 merger guidelines for propositions that do not differ significantly from prior versions of the guidelines, leaving it unclear whether the antitrust agencies will test the guidelines’ more aggressive theories, and how those theories will be treated by federal judges, say attorneys at Covington.

  • Federal Debanking Scrutiny Prompts Compliance Questions

    Author Photo

    Recent U.S. Small Business Administration guidance sets forth requirements for preventing so-called politicized debanking and specific additional instructions for small lenders, but falls short on clarity for larger institutions, leaving lenders of all sizes with questions as they navigate this unique compliance challenge, say attorneys at Cooley.

  • Series

    Writing Novels Makes Me A Better Lawyer

    Author Photo

    Writing my debut novel taught me to appreciate the value of critique and to never give up, no matter how long or tedious the journey, providing me with valuable skills that I now emphasize in my practice, says Daniel Buzzetta at BakerHostetler.

  • SEC's No-Action Relief Could Dramatically Alter Retail Voting

    Author Photo

    The U.S. Securities and Exchange Commission recently cleared the way for ExxonMobil to institute a novel change in retail shareholder voting that could greatly increase voter turnout, granting no-action relief that represents an effective and meaningful step toward modernizing the shareholder voting process and the much-needed democratization of retail investors, say attorneys at Cozen.

  • SDNY OpenAI Order Clarifies Preservation Standards For AI

    Author Photo

    The Southern District of New York’s recent order in the OpenAI copyright infringement litigation, denying discovery of The New York Times' artificial intelligence technology use, clarifies that traditional preservation benchmarks apply to AI content, relieving organizations from using a “keep everything” approach, says Philip Favro at Favro Law.

  • What's At Stake In Justices' Merits Hearing Of FTC Firing

    Author Photo

    In December, the U.S. Supreme Court will review President Donald Trump's firing of Democratic Federal Trade Commissioner Rebecca Slaughter, a decision that will implicate a 90-year-old precedent and, depending on its breadth, could have profound implications for presidential authority over independent agencies, say attorneys at Holland & Knight.

  • 6 Shifts In Trump Tax Law May Lend A Hand To M&A Strategy

    Author Photo

    Changes in the Trump administration's recent One Big Beautiful Bill Act stand to create a more favorable environment for mergers and acquisitions, including full bonus depreciation and an expanded code section, say attorneys at K&L Gates.

  • Hermes Bags Antitrust Win That Clarifies Luxury Tying Claims

    Author Photo

    A California federal court recently found that absent actual harm to competition in the market for ancillary products, Hermes may make access to the Birkin bag contingent on other purchases, establishing that selective sales tactics and scarcity do not automatically violate U.S. antitrust law, say attorneys at Holland & Knight.

  • Opinion

    High Court, Not A Single Justice, Should Decide On Recusal

    Author Photo

    As public trust in the U.S. Supreme Court continues to decline, the court should adopt a collegial framework in which all justices decide questions of recusal together — a reform that respects both judicial independence and due process for litigants, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.

  • Series

    Traveling Solo Makes Me A Better Lawyer

    Author Photo

    Traveling by myself has taught me to assess risk, understand tone and stay calm in high-pressure situations, which are not only useful life skills, but the foundation of how I support my clients, says Lacey Gutierrez at Group Five Legal.

  • Series

    Law School's Missed Lessons: Client Service

    Author Photo

    Law school teaches you how to interpret the law, but it doesn't teach you some of the key ways to keeping clients satisfied, lessons that I've learned in the most unexpected of places: a book on how to be a butler, says Gregory Ramos at Armstrong Teasdale.

  • US-German M&A Hits Its Stride Despite Economic Headwinds

    Author Photo

    Against expectations, dealmakers in both the U.S. and Germany are actively seeking investment opportunities in each other's markets, with 2025 shaping up to be the strongest year in recent memory, say attorneys at White & Case.

  • How Trump Admin. Is Shifting Biden's Antitrust Merger Enforcement

    Author Photo

    Antitrust enforcement trends under the Trump administration have included a moderation in the agencies' approach to merger enforcement as compared to enforcers compared to the prior administration, but dealmakers should still expect aggressive enforcement when the agencies believe consumers will be harmed and they expect to win in court, say attorneys at Rule Garza.

  • Opinion

    Ending Quarterly Reporting Would Erode Investor Protection

    Author Photo

    President Donald Trump recently called for an end to the long-standing practice of corporate quarterly reporting, but doing so would reduce transparency, create information asymmetries, provide more opportunities for corporate fraud and risk increased stock price volatility, while not meaningfully increasing long-term investments, say attorneys at Bleichmar Fonti.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here